Search

Search Constraints

You searched for: Author/Creator Abraham, Christopher

Search Results

2. CTIM-07. A PHASE I/II STUDY EVALUATING THE SAFETY AND EFFICACY OF A NOVEL LONG-ACTING INTERLEUKIN-7, NT-I7, FOR PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS AFTER CHEMORADIOTHERAPY. (12th November 2021)

3. CTIM-10. A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) IN COMBINATION WITH BEVACIZUMAB AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA: NCT03532295. (14th November 2022)

4. Evaluation of interim MRI changes during limited-field radiation therapy for glioblastoma and implications for treatment planning. (May 2021)

5. Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases. (March 2021)

6. SPCR-01 RAPIDPLAN HIPPOCAMPAL SPARING WHOLE BRAIN MODEL VERSION 2 - HOW FAR CAN WE REDUCE THE DOSE?. (5th August 2022)

7. Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). (March 2020)

8. 5th International Symposium on Focused Ultrasound. Issue 1 (November 2016)

9. 5th International Symposium on Focused Ultrasound. Issue 1 (November 2016)

10. Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival. (17th August 2018)